Literature DB >> 10225767

Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid.

H Yamada1, H Yaguchi, K Takamori, H Ogawa.   

Abstract

Forty-two cases of pemphigus vulgaris (PV) and bullous pemphigoid (BP) were treated with plasmapheresis by one of 3 techniques: centrifugation, double filtration plasmapheresis (DFPP), or a combination of the two. Each plasmapheresis resulted in a rapid reduction in the autoantibody titer and an improvement in clinical symptoms, thereby allowing a lower dose of corticosteroid to be administered and remission to be achieved. These findings suggest that plasmapheresis is an effective treatment for PV and BP patients who have been unresponsive to conventional therapy, for those for whom conventional drugs are contraindicated due to complications, and for those who show severe clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10225767     DOI: 10.1111/j.1744-9987.1997.tb00037.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  3 in total

Review 1.  Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature.

Authors:  Brian Chang; Ashok Tholpady; Richard S P Huang; Elena Nedelcu; Yu Bai
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

2.  Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report.

Authors:  Hiba Hasan Khaddour; Diana Zaher; Triak Kassem; Ahmad Hasan
Journal:  J Med Case Rep       Date:  2020-07-19

Review 3.  Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.

Authors:  Tanja Fetter; Dennis Niebel; Christine Braegelmann; Joerg Wenzel
Journal:  Cells       Date:  2020-12-07       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.